Paying people to take COVID vaccine worked well, study finds Paying people to take a first COVID-19 vaccine dose didn't lower the likelihood of seeking the second or third dose or of other positive health behaviors. CIDRAP

A study finds that paying people to take a first dose of a COVID-19 vaccine didn't lower the likelihood of seeking the second or third dose or of other positive health behaviors and didn't erode morals, sense of civic duty, or feelings of self-determination.

EU court: Tourists may get refunds over COVID measures BERLIN (AP) — Travelers whose package tours were ruined by the imposition of restrictions to combat the COVID-19 pandemic may be entitled to at least a partial refund, the European Union's highest court said Thursday. AP NEWS

...

Why it’s easier to catch a cold, the flu or COVID in the winter Low humidity protects viruses and cold temperatures may blunt some immune responses, making viral infections like colds, flu and COVID-19 more likely. Tina Hesman Saey Science News

...researchers have found that viruses that surge in the winter, including influenza viruses and SARS-CoV-2 — the coronavirus that causes COVID-19 — survive best when the relative humidity in the air falls below about 40 percent.

...

How Long Are You Protected After A COVID Infection Now? COVID cases are rising as the new XBB subvariant spreads. Are you at risk for reinfection if you recently had the virus? YahooNews

...

Exactly how long protection lasts after a COVID infection isn’t one-size-fits-all. A few factors make it impossible to say exactly how long you’re protected from reinfection.

WHO weighs in on Omicron XBB.1.5 subvariant; US extends COVID health emergency CIDRAP

The World Health Organization (WHO) advisory group on virus evolution said the Omicron XBB.1.5 subvariant is poised to drive an increase in COVID-19 cases, but it cautioned that confidence in its assessment is low, because most of the information is based on data from just one country—the United States.

...

Mpox has faded in the US. Who deserves the credit? NEW YORK (AP) — Less than six months ago, mpox was an exploding health crisis. What had been an obscure disease from Africa was ripping through European and U.S. gay communities. Precious doses of an unproven vaccine were in short supply. AP NEWS

...

So who deserves the credit? It’s an unsettled question, but experts cite a combination of factors.

Bivalent COVID vaccines have now been in use for a few months—here's how they're stacking up against omicron Vaccines have played a major role in mitigating the harms of the COVID pandemic since their rollout began just over two years ago. They're estimated to have saved tens of millions of lives across the ... Neil Mabbott

...

What's standing in the way of wastewater data becoming a more mainstream public health tool When case counts suggest Covid-19 is in check, the truth is in the toilets. Brittany Trang STAT

...

U.S. extends public health emergency status for COVID The U.S. health department on Wednesday extended the COVID-19 pandemic's status as a public health emergency, allowing millions of Americans to continue receiving free tests, vaccines and treatments. Ahmed Aboulenein Reuters

...

Uganda declares itself Ebola-free after swiftly turning tide on outbreak Uganda on Wednesday declared the end of a nearly four-month Ebola outbreak that it briefly struggled to contain but was then able to swiftly bring under control despite the absence of a proven vaccine against the viral strain in question. Elias Biryabarema Reuters

...

The latest outbreak killed 55 of the 143 people infected since September, according to health ministry figures. Six of the fatalities were health workers.

...